Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Total Liabilities (2017 - 2025)

Inspire Medical Systems' Total Liabilities history spans 9 years, with the latest figure at $126.2 million for Q4 2025.

  • For Q4 2025, Total Liabilities rose 6.29% year-over-year to $126.2 million; the TTM value through Dec 2025 reached $126.2 million, up 6.29%, while the annual FY2025 figure was $126.2 million, 6.29% up from the prior year.
  • Total Liabilities for Q4 2025 was $126.2 million at Inspire Medical Systems, down from $141.3 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $141.3 million in Q3 2025 and bottomed at $50.3 million in Q1 2021.
  • The 5-year median for Total Liabilities is $89.6 million (2023), against an average of $86.6 million.
  • The largest annual shift saw Total Liabilities decreased 2.18% in 2022 before it soared 66.29% in 2023.
  • A 5-year view of Total Liabilities shows it stood at $66.0 million in 2021, then increased by 4.29% to $68.9 million in 2022, then surged by 51.44% to $104.3 million in 2023, then grew by 13.8% to $118.7 million in 2024, then rose by 6.29% to $126.2 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Total Liabilities are $126.2 million (Q4 2025), $141.3 million (Q3 2025), and $124.4 million (Q2 2025).